Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $9,069 | 5 | 58.6% |
| Food and Beverage | $5,720 | 271 | 37.0% |
| Travel and Lodging | $689.94 | 5 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $9,926 | 15 | $0 (2022) |
| Astellas Pharma US Inc | $1,226 | 65 | $0 (2024) |
| ABBVIE INC. | $658.86 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $587.18 | 32 | $0 (2024) |
| NeoTract Inc. | $520.63 | 17 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $388.31 | 15 | $0 (2024) |
| PFIZER INC. | $322.38 | 21 | $0 (2024) |
| Boston Scientific Corporation | $263.50 | 12 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $231.54 | 12 | $0 (2024) |
| Stryker Corporation | $166.67 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,004 | 43 | Sumitomo Pharma America, Inc. ($210.33) |
| 2023 | $1,008 | 37 | Astellas Pharma US Inc ($209.72) |
| 2022 | $163.01 | 7 | Intuitive Surgical, Inc. ($92.98) |
| 2020 | $368.33 | 20 | Astellas Pharma US Inc ($146.36) |
| 2019 | $11,041 | 71 | Intuitive Surgical, Inc. ($9,805) |
| 2018 | $1,080 | 65 | Janssen Biotech, Inc. ($240.54) |
| 2017 | $814.04 | 38 | Astellas Pharma US Inc ($241.56) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/15/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Urology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Oncology | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: HORMONE THERAPY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Wound Closure | ||||||
| 09/23/2024 | C. R. Bard, Inc. & Subsidiaries | — | Food and Beverage | In-kind items and services | $13.57 | General |
| 09/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: HORMONE THERAPY | ||||||
| 08/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: HORMONE THERAPY | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: UROLOGY | ||||||
| 06/25/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Oncology | ||||||
| 04/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,120 | 1,536 | $376,775 | $105,980 |
| 2022 | 15 | 877 | 1,183 | $282,083 | $93,286 |
| 2021 | 15 | 886 | 1,405 | $327,409 | $84,810 |
| 2020 | 15 | 946 | 1,439 | $393,448 | $95,520 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 300 | 500 | $126,500 | $34,957 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 141 | $50,196 | $15,364 | 30.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 48 | 59 | $33,276 | $12,744 | 38.3% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 16 | 57 | $20,098 | $7,137 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $27,634 | $7,087 | 25.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 47 | $24,910 | $6,693 | 26.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 18 | 18 | $11,484 | $3,936 | 34.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 22 | 26 | $16,406 | $3,351 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $11,986 | $3,257 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 42 | $8,022 | $2,845 | 35.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 23 | 28 | $7,952 | $1,927 | 24.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 23 | $4,980 | $1,389 | 27.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $5,328 | $1,334 | 25.0% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 22 | 24 | $8,080 | $1,052 | 13.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 167 | 237 | $6,162 | $801.13 | 13.0% |
| 51703 | Complicated insertion of bladder tube | Facility | 2023 | 11 | 11 | $3,382 | $709.94 | 21.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 104 | 129 | $4,257 | $503.15 | 11.8% |
| 51700 | Simple bladder irrigation and/or instillation | Facility | 2023 | 12 | 15 | $4,260 | $380.10 | 8.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 32 | 35 | $1,050 | $345.44 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 11 | $539.00 | $140.14 | 26.0% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 13 | 13 | $273.00 | $28.67 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 296 | 532 | $109,368 | $37,407 | 34.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 47 | 64 | $36,096 | $14,242 | 39.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 146 | 146 | $36,786 | $12,703 | 34.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 61 | 62 | $24,652 | $9,884 | 40.1% |
About Dr. Gerald Yoon, M.D
Dr. Gerald Yoon, M.D is a Urology healthcare provider based in Whittier, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477602308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Yoon, M.D has received a total of $15,479 in payments from pharmaceutical and medical device companies, with $1,004 received in 2024. These payments were reported across 281 transactions from 29 companies. The most common payment nature is "Education" ($9,069).
As a Medicare-enrolled provider, Yoon has provided services to 3,829 Medicare beneficiaries, totaling 5,563 services with total Medicare billing of $379,596. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Whittier, CA
- Active Since 01/09/2007
- Last Updated 03/26/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1477602308
Products in Payments
- Da Vinci Surgical System (Device) $9,926
- XTANDI (Drug) $929.87
- Erleada (Drug) $389.78
- UroLift (Device) $326.10
- Xtandi (Drug) $278.38
- Myrbetriq (Drug) $251.67
- GEMTESA (Drug) $213.60
- BOTOX (Biological) $208.79
- Urolift - UL400 (Device) $194.53
- ORGOVYX (Drug) $174.71
- IVAS (Device) $166.67
- ERLEADA (Drug) $162.00
- Androgel (Drug) $160.56
- Nubeqa (Drug) $146.32
- LUPRON DEPOT (Drug) $127.52
- UROLIFT (Device) $122.40
- Lupron Depot (Drug) $120.94
- MYRBETRIQ (Drug) $117.07
- AQUABEAM SYSTEM (Device) $104.81
- KEYTRUDA (Biological) $98.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Whittier
Pooya Banapour
Urology — Payments: $43,273
Dr. Sepehr Nowfar, M.d, M.D
Urology — Payments: $17,729
Dr. Jason Lai, M.d, M.D
Urology — Payments: $15,848
Dr. Shahrad Aynehchi, Md, MD
Urology — Payments: $6,327
Dr. Scott Yun, M.d, M.D
Urology — Payments: $3,227
Dr. Vinh Trang, M.d, M.D
Urology — Payments: $2,019